These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31670197)

  • 21. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
    Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
    Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
    Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP
    Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD
    Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.
    Hollink IH; Zwaan CM; Zimmermann M; Arentsen-Peters TC; Pieters R; Cloos J; Kaspers GJ; de Graaf SS; Harbott J; Creutzig U; Reinhardt D; van den Heuvel-Eibrink MM; Thiede C
    Leukemia; 2009 Feb; 23(2):262-70. PubMed ID: 19020547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia.
    Lai R; Zhang W; He X; Liao X; Liu X; Fu W; Yang P; Wang J; Hu K; Yuan X; Zhang X; Jing H; Liu W
    J Cancer; 2020; 11(17):5150-5161. PubMed ID: 32742462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia.
    Papaioannou D; Nicolet D; Ozer HG; Mrózek K; Volinia S; Fadda P; Carroll AJ; Kohlschmidt J; Kolitz JE; Wang ES; Stone RM; Byrd JC; Garzon R; Bloomfield CD
    Mol Cancer Ther; 2019 Aug; 18(8):1451-1459. PubMed ID: 31164409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
    J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia.
    Huang S; Huang Z; Ma C; Luo L; Li YF; Wu YL; Ren Y; Feng C
    Ann Transl Med; 2020 Mar; 8(6):345. PubMed ID: 32355789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relevance of Wilms tumor 1 (WT1) gene Exon 7 mutations in-patient with cytogenetically normal acute myeloid leukemia.
    Aref S; El Sharawy S; Sabry M; Azmy E; Raouf DA
    Indian J Hematol Blood Transfus; 2014 Dec; 30(4):226-30. PubMed ID: 25435718
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Zhou JD; Yao DM; Li XX; Zhang TJ; Zhang W; Ma JC; Guo H; Deng ZQ; Lin J; Qian J
    Oncotarget; 2017 Sep; 8(39):66087-66097. PubMed ID: 29029494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
    Baldus CD; Bullinger L
    Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia.
    Aref S; Al Khodary T; Zeed TA; El Sadiek A; El Menshawy N; Al Ashery R
    Indian J Hematol Blood Transfus; 2015 Mar; 31(1):21-8. PubMed ID: 25548440
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
    Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia.
    Walker CJ; Kohlschmidt J; Eisfeld AK; Mrózek K; Liyanarachchi S; Song C; Nicolet D; Blachly JS; Bill M; Papaioannou D; Oakes CC; Giacopelli B; Genutis LK; Maharry SE; Orwick S; Archer KJ; Powell BL; Kolitz JE; Uy GL; Wang ES; Carroll AJ; Stone RM; Byrd JC; de la Chapelle A; Bloomfield CD
    Clin Cancer Res; 2019 Nov; 25(21):6524-6531. PubMed ID: 31375516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia.
    Wang M; Yang C; Zhang L; Schaar DG
    Stem Cells Int; 2017; 2017():6962379. PubMed ID: 28197208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Multi-Omic Prognostic Model of Oxidative Stress-Related Genes in Acute Myeloid Leukemia.
    Dong C; Zhang N; Zhang L
    Front Genet; 2021; 12():722064. PubMed ID: 34659343
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune prognostic risk score model in acute myeloid leukemia with normal karyotype.
    Dong X; Zhang D; Zhang J; Chen X; Zhang Y; Zhang Y; Zhou X; Chen T; Zhou H
    Oncol Lett; 2020 Dec; 20(6):380. PubMed ID: 33154778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.